Company intelligence / Profile preview

Fujii

Chiyoda-ku, Tokyo, Japan

Ownership: Private
Employees: ~1658
Development stage: Other

Overview

Fuji Pharma develops, manufactures, and markets pharmaceutical products including injection agents, internal drugs, external use drugs, and diagnostic products. The company has an established commercial presence with particular strengths in women’s health and acute medical care. It operates R&D facilities in Japan and has an overseas group company in Thailand. No detailed clinical trial results are publicly summarized.

Therapeutic areas: Women's HealthOther
Modalities: Small moleculeBiologicDiagnostic agent
Industry: Biotech

Partnerships

Not specifically listed; OLIC provides contract manufacturing services which may involve partnerships.

Beyond the preview

Go deeper on Fujii.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fujii.

Explore the full profile